IART.NASDAQIntegra Lifesciences Holdings CORP

Form 4: Integra LifeSciences EVP & CHRO Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Integra Lifesciences Holdings CORP
🔒Login to Follow

Chantal Veillon-Berteloot, EVP & CHRO of Integra LifeSciences, reports acquisition and disposal of company stock and stock options.

Summary

  • Chantal Veillon-Berteloot, EVP & CHRO of Integra LifeSciences Holdings Corp, filed a Form 4 on March 13, 2025.
  • The report details transactions made on March 11, 2025.
  • Veillon-Berteloot disposed of 524 shares of common stock at a price of $23.95.
  • She also acquired 7,343 shares of common stock.
  • Following these transactions, she directly owns 31,198 shares of common stock.
  • Veillon-Berteloot also acquired 15,549 non-qualified stock options with an exercise price of $23.95, exercisable starting March 11, 2025, and expiring on March 11, 2033.
  • She directly owns 15,549 non-qualified stock options.

Sentiment

Score: 5

Explanation: This is a neutral filing, simply reporting required information about stock transactions. There's no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of key personnel.

Stakeholder Impact

  • The transactions may be of interest to shareholders as they provide insight into the actions of a key executive.

Key Dates

DateDescription
03/11/2025Date of earliest transaction: disposal of stock, acquisition of stock, and acquisition of stock options.
03/11/2025Stock options become exercisable.
03/13/2025Date of Form 4 filing.
03/11/2033Expiration date of stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.